Gujarat Kidney IPO: An Analysis
The Gujarat Kidney and Super Speciality Hospital IPO saw significant investor interest, but let’s break down exactly what happened. The IPO originally offered 1.32 crore shares, but investors placed bids for a massive 1.94 crore shares. This means demand was much higher than expected, and the issue was ultimately subscribed 1.47 times – that’s a lot of shares wanted!
Key Points
- IPO offered 1.32 crore shares, bids reached 1.94 crore.
- Issue subscribed 1.47 times, exceeding initial expectations significantly.
- Price band set at Rs 108-114 per share for the IPO.
- Funds will finance hospital acquisitions, equipment, and debt repayment.
- Anchor investors contributed Rs 100.01 crore pre-IPO allotment.
- Promoter stake will decrease, owning approximately 71.45% post-issue.
IPO Details
The IPO was open for bidding from December 22nd to December 24th, 2025, with a price range of Rs 108 to Rs 114 per share. The company was raising up to Rs 250.8 crore through this offering. This money is planned to be used to grow the hospital and expand its operations.
How the Money Will Be Used
The hospital wants to use the money from the IPO to buy the Parekhs Hospital in Ahmedabad. They also want to make part payments for the Ashwini Medical Centre. Additionally, they plan to increase their ownership stake in Harmony Medicare, purchase robotics equipment, and pay down debt.
Anchor Investors
Before the public offering, Gujarat Kidney secured Rs 100.01 crore from 10 anchor investors by offering them 87.73 million shares at Rs 114 each. This early investment shows confidence in the company’s future.
Ownership Changes
Currently, the company’s founder and promoters own nearly all of the shares. After the IPO, this ownership will reduce to around 71.45%. This demonstrates a shift towards broader shareholder ownership.
Financial Performance
For the period ending June 30, 2025, the hospital reported a profit of Rs 4.84 crore and revenue of Rs 15.26 crore, demonstrating solid financial health. These results support investor confidence in the company’s growth potential.
Expanding healthcare infrastructure with strategic investments is key to long-term success.
